PET imaging of gene expression

European Journal of Cancer

Volumn 38, Issue 16, 2002, Pages 2137-2146

  Blasberg, Ronald ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

FIAU; Gamma camera; Gene imaging; Herpes virus type one thymidine kinase; HSV1 tk; Molecular imaging; NFAT; p53; PET; T cell activation

Indexed keywords

GANCICLOVIR; PROTEIN P53; RECOMBINANT DNA; T LYMPHOCYTE RECEPTOR;

COLORECTAL CANCER; DNA VECTOR; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; IMAGING SYSTEM; ISOTOPE LABELING; LIVER CANCER; NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVIEW; SCINTILLATION CAMERA; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0036828054     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00390-8     Document Type: Article

References (49)

1. Wick R.A. Photon counting imaging. applications in biomedical research Biotechniques. 7:1989;262-269.
2. Hooper C.E., Ansorge R.E., Browne H.M., Tomkins P. CCD imaging of luciferase gene expression in single mammalian cells. Journal of Bioluminescence & Chemiluminescence. 5:1990;123-130.
3. Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells. Lab Anim Sci 1993;43(1):48-57.
4. Welsh S., Kay S.A. Reporter gene expression for monitoring gene transfer. Current Opinion in Biotechnology. 8:1997;617-622.
5. Doubrovin M., Ponomarev V., Beresten T.et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. PNAS. 98:2001;9300-9305.
6. Behr T.M., Gotthardt M., Barth A., Behe M. Imaging tumors with peptide-based radioligands. Q. J. Nucl. Med. 45:2001;189-200.
7. Dewanjee M.K., Ghafouripour A.K., Kapadvanjwala M.et al. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. Nucl. Med. 35:1994;1054-1063.
8. Cammilleri S., Sangrajrang S., Perdereau B.et al., Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injection. Eur. J. Nucl. Med. 23:1996;448-452.
9. Phillips JA, Craig SJ, Bayley D, Christian RA, Geary R, Nicklin PL. Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration. Biochem Pharmacol 1997;15;54(6):657-68.
10. Tavitian B., Terrazzino S., Kuhnast B.et al. In vivo imaging of oligonucleotides with positron emission tomography. Nat. Med. 4:1998;467-471.
11. Reivich M., Kuhl D., Wolf A.et al. Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol. Scand. Suppl. 64:1977;190-191.
12. Sokoloff L., Reivich M., Kennedy C.et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28:1977 May;897-916.
13. Sokoloff L. [1-14C]-2-deoxy-d-glucose method for measuring local cerebral glucose utilization. Mathematical analysis and determination of the "lumped" constants. Neurosci. Res. Program Bull. 14:1976;466-468.
14. Sokoloff L. Metabolic probes for localization of functional activity in the central nervous system. Int. J. Neurol. 18:1984;40-48.
15. Schmidt K.C., Lucignani G., Sokoloff L. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization. a re-examination J. Nucl. Med. 37:1996;394-399.
16. Jones D.E. Jr., Cui D.M., Miller D.M. Expression of beta-galactosidase under the control of the human c-myc promoter in transgenic mice is inhibited by mithramycin. Oncogene. 10:1995;2323-2330.
17. Tjuvajev J.G., Stockhammer G., Desai R.et al. Imaging the expression of transfected genes in vivo. Cancer Research. 55:1995;6126-6132.
18. Tjuvajev J.G., Finn R., Watanabe K.et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression. a potential method for monitoring clinical gene therapy Cancer Research. 56:1996;4087-4095.
19. Tjuvajev J.G., Avril N., Oku T.et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Research. 58:1998;4333-4341.
20. Gambhir S.S., Barrio J.R., Wu L.et al. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 39:1998;2003-2011.
21. Gambhir S.S., Barrio J.R., Phelps M.E.et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. USA. 96:1999;2333-2338.
22. Weissleder R., Reimer P., Lee A.S., Wittenberg J., Brady T.J. MR receptor imaging. ultrasmall iron oxide particles targeted to asialoglycoprotein receptors Am. J. Roentgenol. 155:1990;1161-1167.
23. Weissleder R., Lee A.S., Fischman A.J.et al. Polyclonal human immunoglobulin G labeled with polymeric iron oxide. antibody MR imaging Radiology. 181:1991;245-249.
24. Kayyem J.F., Kumar R.M., Fraser S.E., Meade T.J. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem. Biol. 2:1995;615-620.
25. Weissleder R., Simonova M., Bogdanova A.et al. MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 204:1997;425-429.
26. Louie A.Y., Huber M.M., Ahrens E.T.et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:2000;321-325.
27. Mayerhofer R., Araki K., Szalay A.A. Monitoring of spatial expression of firefly luciferase in transformed zebrafish. Journal of Bioluminescence & Chemiluminescence. 10:1995;271-275.
28. Bennett J., Duan D., Engelhardt J.F., Maguire A.M. Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction. Investigative Ophthalmology & Visual Science. 38:1997;2857-2863.
29. Rehemtulla A., Stegman L.D., Cardozo S.J.et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:2000;491-495.
30. Gambhir S.S., Bauer E., Black M.E.et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl. Acad. Sci. USA. 97:2000;2785-2790.
31. MacLaren D.C., Gambhir S.S., Satyamurthy N.et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6:1999;785-791.
32. Rogers B.E., McLean S.F., Kirkman R.L., Della Manna D., Bright S.J., Olsen C.C., Myracle A.D., Mayo M.S., Curiel D.T., Buchsbaum D.J. In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector. Clin. Cancer Res. 5:1999 Feb;383-393.
33. Rogers B.E., Zinn K.R., Buchsbaum D.J. Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q. J. Nucl. Med. 44:2000;208-223.
34. 18F]fluoroethyl)spiperone. in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans Journal of Cerebral Blood Flow and Metabolism. 9:1989;830-839.
35. Hemminki A., Belousova N., Zinn K.R.et al. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol. Ther. 4:2001;223-231.
36. Jolly D. Viral vector systems for gene delivery. Cancer Gene Therapy. 1:1994;51-64.
37. Naylor L.H. Reporter gene technology. the future looks bright Biochemical Pharmacology. 58:1999;749-757.
38. 124I]FIAU and PET. Molecular Imaging. 1:2002;36-42.
39. Tjuvajev J.G., Chen S.H., Joshi A.et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59:1999;5186-5193.
40. Qiao J., Doubrovin M., Bernhard V.S.et al. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Therapy. 9:2002;168-175.
41. Bennett J.J., Tjuvajev J.G., Johnson P.et al. Positron emission tomography imaging for herpes virus infection. implications for oncolytic viral treatments of cancer Nat Med. 7:2001;859-863.
42. Jacobs A., Tjuvajev J.G., Dubrovin M.et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res. 61:2001;2983-2995.
43. Tjuvajev J.G., Joshi A., Callegari J.et al. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia. 1:1999;315-320.
44. Yu Y., Annala A.J., Barrio J.R.et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat. Med. (8). 2000;933-937.
45. Yaghoubi S.S., Wu L., Liang Q.et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther. 8:2001;1072-1080.
46. Pelletier S. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:1988;320.
47. Sachs A.B., Sarnow P., Hentze M.W. Starting at the beginning, middle, and end. translation initiation in eukaryotes Cell. 89:1997;831-838.
48. Merritt J.A., Roth J.A., Logothetis C.J. Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies. Semin Oncol. 28(5 Suppl 16):2001;105-114.
49. Ponomarev V., Doubrovin M., Lyddane C.et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia. 3:2001;480-488.